TransCode publishes preclinical data on glioblastoma treatment
Go back to TransCode publishes preclinical data on glioblastoma treatment| (NASDAQ: RNAZ) | Delayed: 4.59 +0.37 (8.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.22 | 52 Week High | $ | |||
| Open | $4.38 | 52 Week Low | $ | |||
| Day High | $4.72 | P/E | N/A | |||
| Day Low | $4.38 | EPS | $ | |||
| Volume | 2,958 | |||||

